The Adam Smith Institute, in conjunction with the Conservative Drug Policy Reform Group (CDPRG), has published a new report outlining the medical potential of psilocybin and the need to reduce restrictions on research and treatmen
Bibliography: All Publications
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report
This report describes the development of a national model of remote care to eliminate waiting lists and increase access to OAT in Ireland (BMC)
Provisional Drug Overdose Death Counts
This data visualization presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System (CDC)
National Drug Strategy Household Survey 2019
This report presents key results from the 2019 National Drug Strategy Household Survey. It looks at people’s drug use throughout their lives and during the last 12 months, and examines how these patterns have changed over time (AIHW)
Summing it up: Building evidence to inform advocacy for harm reduction funding in Asia
Harm Reduction International developed tools for assessing national harm reduction investment and spending on drug law enforcement. This report presents the research findings generated by these tools in seven Asian countries. It provides insights on the state of harm reduction financing, informed by donor and government stakeholders, civil society and community representatives (HRI)
Youth Violence Commission Final Report (PDF)
While the magnitude of the effort needed to protect young people from serious violence cannot be underestimated, we believe there is cause for cautious optimism (YVC)
Prescription Opioids (Canadian Drug Summary)
Summarizes data on the use of prescription opioids, including information on associated harms and effects, legal status, costs, hospitalization, emergency department visits and access to treatment (CCSA)
Drug treatment in Ireland 2013 to 2019
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland (HRB)
Canadian Substance Use Costs and Harms (2015-2017)
This report provides a summary of key findings about the costs and harms of substance use in Canada from 2015 to 2017 (CCSA)
COVID-19, Prisons and Drug Policy
Detention settings are high-risk environments for the spread of infectious diseases. As such, COVID-19 has posed unprecedented challenges for governments and prison administrations, catalysing the uptake of exceptional measures around the world to decongest prisons (Harm Reduction International)
Saving Lives in the time of COVID-19
Case Study of Harm Reduction, Homelessness and Drug Use in Dublin, Ireland (LSE)
Review of literature on illegal drugs in the region
This document presents a summary of academic research papers on illegal drugs (CESED, Colombia)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Addiction Services in Northern Ireland
This report provides an overview of the scale of alcohol and drug addiction in Northern Ireland, the structures and systems in place within the health sector for tackling addiction, and the challenges faced by those accessing addiction services (NIAO)
Drugs, Prisons and ‘Unintended Consequences’ – Does drug interdiction drive drug-related harms?
The availability and use of drugs in prisons cannot be separated from wider drug policy. The criminalisation of drugs and the people who use or sell them fuels mass incarceration in many countries, and in doing so creates large profitable markets for drugs behind bars (Gdpo)
Philippines: New report reveals deliberate killings of children during “war on drugs”
A new report, published today, documents 122 killings of children, from 1 to 17 years old, throughout the Philippines, between July 2016 and December 2019 (OMCT)
Drugs, Prisons and ‘Unintended Consequences’ – Does drug interdiction drive drug-related harms?
If governments are truly serious about addressing drug use and reducing drug-related harm, they must move away from enforcement-focussed responses, and instead implement laws and policies that reduce the number of people in prison for drug-related offences, and to provide comprehensive harm reduction programmes for people in detention (Global Drug Policy Observatory)
Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia
Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020 (NDARC)
Alcohol and other drug treatment services in Australia, 2018–19
In 2018–19, 1,283 publicly funded alcohol and other drug (AOD) treatment services provided just under 220,000 treatment episodes to an estimated 137,000 clients (AIHW)
World Drug Report 2020
Presented in six separate booklets, the World Drug Report 2020 provides a wealth of information and analysis to support the international community in implementing operational recommendations on a number of commitments made by Member States, including the recommendations contained in the outcome document of the special session of the General Assembly on the world drug problem, held in 2016 (UNODC)
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 76
- Next Page »
